Alimta and malignant neoplasm progression 
Alimta and malignant neoplasm progression Patient Reports February 12, 2012
Alimta Side Effects Report #4776346-4
Alimta side effect was reported by a Physician from AUSTRALIA on Sept 06, 2005. Female patient, 75 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: confusional state, loss of consciousness, malignant neoplasm progression, mesothelioma
, metastases to central nervous system. Alimta dosage: unknown. During the same period patient was treated with VITAMIN B, FOLIC ACID, CARBOPLATIN. Patient was hospitalized. Patient died on 01/01/2005.Alimta Side Effects Report #4906854-4
Alimta side effect was reported by a Physician from AUSTRALIA on Jan 25, 2006. Female patient, 75 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: confusional state, loss of consciousness, malignant neoplasm progression, mesothelioma
. Alimta dosage: unknown. During the same period patient was treated with VITAMIN B, FOLIC ACID, CARBOPLATIN. Patient was hospitalized. Patient died on 01/01/2005.Alimta Side Effects Report #4901157-6
Alimta side effect was reported by a Health Professional from UNITED STATES on Jan 11, 2006. Male patient, 73 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: disease progression, malignant neoplasm progression, nausea
. Alimta dosage: 700 MG, OTHER, INTRAVENOUS. During the same period patient was treated with CISPLATIN, VITAMIN B12. Patient was hospitalized. Patient died on 10/05/2005.Alimta Side Effects Report #5557903-4
Alimta side effect was reported by a Physician from FRANCE on Dec 05, 2007. Male patient, 61 years of age, was diagnosed with pleural mesothelioma, vitamin supplementation, prophylaxis and was treated with Alimta. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, neutropenia, renal failure. Alimta dosage: 500 MG/M2, OTHER. During the same period patient was treated with CISPLATIN, FOLIC ACID, VITAMIN B, CORTICOSTEROIDS. Patient died.
Alimta Side Effects Report #4848723-4
Alimta side effect was reported by a Physician from GERMANY on Nov 24, 2005. Male patient, 61 years of age, was diagnosed with pleural mesothelioma and was treated with Alimta. After drug was administered, patient experienced the following side effects: animal bite
, blister, disease recurrence, embolism, hypoxia, malignant neoplasm progression, microangiopathy, neuropathy, oedema peripheral. Alimta dosage: 500 MG/M2, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, LAFOL, VITAMIN B12, NEXIUM, OXYGEN, CONTRAST MEDIA. Patient was hospitalized. Patient recovered.Alimta Side Effects Report #4595286-7
Alimta side effect was reported by a Health Professional from on Feb 09, 2005. Male patient, 57 years of age, weighting 242.5 lb, was diagnosed with peritoneal mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: abdominal adhesions, anorexia, cardiomegaly, cholelithiasis, fat necrosis, hepatic failure, liver palpable subcostal, malignant neoplasm progression, metastases to liver. Alimta dosage: 500 MG/M2. During the same period patient was treated with CISPLATIN, VITAMIN B, DEXAMETHASONE, LISINOPRIL, LEVAQUIN, ARANESP. Patient was hospitalized. Patient died on 01/24/2005.
Alimta Side Effects Report #5852878-2
Alimta side effect was reported by a Physician from JAPAN on Aug 11, 2008. Male patient, weighting 123.5 lb, was diagnosed with peritoneal mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: ileus, malignant neoplasm progression. Alimta dosage: 770 MG, OTHER. During the same period patient was treated with PANVITAN, CYANOCOBALAMIN. Patient was hospitalized. Patient died on 06/06/2008.
Alimta Side Effects Report #5917121-4
Alimta side effect was reported by a Physician from JAPAN on Oct 07, 2008. Male patient, weighting 123.5 lb, was diagnosed with peritoneal mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: ileus, malignant neoplasm progression. Alimta dosage: 770 MG, OTHER. During the same period patient was treated with PANVITAN, CYANOCOBALAMIN. Patient died on 06/06/2008.
Alimta Side Effects Report #5339541-1
Alimta side effect was reported by a Physician from UNITED STATES on Jan 19, 2007. Male patient, 73 years of age, was diagnosed with non-small cell lung cancer stage iv and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, malignant neoplasm progression, thrombocytopenia. Alimta dosage: unknown. Patient recovered.
Alimta Side Effects Report #5553946-5
Alimta side effect was reported by a Physician from UNITED STATES on Dec 03, 2007. Female patient, 71 years of age, weighting 209.0 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Alimta. After drug was administered, patient experienced the following side effects: chills, fatigue, hepatic infarction, malignant neoplasm progression, nausea
. Alimta dosage: 975 MG, OTHER. During the same period patient was treated with VITAMIN B, FOLIC ACID, DEXAMETHASONE. Patient was hospitalized. Patient died on 08/14/2007.Alimta Side Effects Report #5039443-4
Alimta side effect was reported by a Consumer or non-health professional from UNITED STATES on June 07, 2006. Female patient, 70 years of age, weighting 127.0 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Alimta. After drug was administered, patient experienced the following side effects: buttock pain, depression
, dysphoria, fatigue, malignant neoplasm progression, nausea , non-small cell lung cancer metastatic, spinal disorder, tremor. Alimta dosage: unknown. During the same period patient was treated with CYANOCOBALAMIN, FOLIC ACID. Patient recovered.Alimta Side Effects Report #4684806-X
Alimta side effect was reported by a Health Professional from on Feb 17, 2005. Female patient, 67 years of age, was diagnosed with non-small cell lung cancer stage iv and was treated with Alimta. After drug was administered, patient experienced the following side effects: constipation
, malignant neoplasm progression. Alimta dosage: unknown. During the same period patient was treated with FOLIC ACID, VITAMIN B, DEXAMETHASONE. Patient recovered.Alimta Side Effects Report #5628196-4
Alimta side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2008. Female patient, 63 years of age, weighting 290.3 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, bronchitis
, epistaxis, malignant neoplasm progression, petechiae, rash erythematous, renal failure, stomatitis, thrombocytopenia. Alimta dosage: 500 MG, UNK. During the same period patient was treated with CARBOPLATIN, VITAMIN B, FOLIC ACID, LEVAQUIN, VANCOMYCIN HYDROCHLORIDE, CEFTRIAXONE, FLUCONAZOLE. Patient was hospitalized. Patient died on 01/26/2008.Alimta Side Effects Report #6065301-2
Alimta side effect was reported by a Physician from UNITED STATES on Jan 29, 2009. Male patient, weighting 235.0 lb, was diagnosed with non-small cell lung cancer stage iv, atrial fibrillation
and was treated with Alimta. After drug was administered, patient experienced the following side effects: anorexia, cardiac failure congestive, chest pain , chronic obstructive pulmonary disease, dyspnoea, malignant neoplasm progression, pancytopenia, rash pruritic. Alimta dosage: 1190 MG, OTHER. During the same period patient was treated with FOLIC ACID, SIMVASTATIN, NEXIUM, COUMADIN, VICODIN, ALBUTEROL SULPHATE. Patient was hospitalized. Patient recovered.Alimta Side Effects Report #4666568-5
Alimta side effect was reported by a Pharmacist from on May 04, 2005. Male patient, 80 years of age, was diagnosed with non-small cell lung cancer stage iiib and was treated with Alimta. After drug was administered, patient experienced the following side effects: cardiac tamponade, chronic obstructive pulmonary disease, hepatic congestion, hepatic failure, ischaemic hepatitis, malignant neoplasm progression, non-small cell lung cancer, pericardial effusion malignant, pericarditis. Alimta dosage: 870 MG. During the same period patient was treated with VITAMIN B, FOLIC ACID, DEXAMETHASONE, AMBIEN, SALMETEROL, SIMVASTATIN. Patient was hospitalized. Patient died on 03/19/2005.
Alimta Side Effects Report #5993782-9
Alimta side effect was reported by a Physician from SWITZERLAND on Dec 04, 2008. Male patient, 42 years of age, was diagnosed with non-small cell lung cancer metastatic, prophylaxis and was treated with Alimta. After drug was administered, patient experienced the following side effects: abdominal pain
, dyspnoea, liver injury, malignant neoplasm progression, mucosal inflammation, oesophageal candidiasis, pancytopenia, renal failure acute. Alimta dosage: unknown. During the same period patient was treated with FOLIC ACID, TEMESTA, NEXIUM. Patient was hospitalized. Patient died on 11/21/2008.Alimta Side Effects Report #5482681-7
Alimta side effect was reported by a Physician from UNITED STATES on Sept 28, 2007. Female patient, weighting 136.0 lb, was diagnosed with non-small cell lung cancer metastatic, musculoskeletal pain and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, dehydration, hypokalaemia, malignant neoplasm progression. Alimta dosage: unknown. During the same period patient was treated with NAVELBINE, PREVACID, IRON SULPHATETHIAMIN COMPOUND, FLEXERIL, FOLIC ACID, DECADRON, OXYCONTIN. Patient was hospitalized. Patient died on 09/08/2007.
Alimta Side Effects Report #5505379-5
Alimta side effect was reported by a Physician from UNITED STATES on Oct 25, 2007. Female patient, weighting 136.0 lb, was diagnosed with non-small cell lung cancer metastatic, pain in extremity, musculoskeletal pain and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, dehydration, hypokalaemia, malignant neoplasm progression, oral intake reduced, weight decreased. Alimta dosage: unknown. During the same period patient was treated with NAVELBINE, PREVACID, IRON SULPHATETHIAMIN COMPOUND, FLEXERIL, FOLIC ACID, DECADRON, OXYCONTIN. Patient was hospitalized. Patient died on 09/08/2007.
Alimta Side Effects Report #5645020-4
Alimta side effect was reported by a Physician from UNITED STATES on Feb 20, 2008. Male patient, weighting 147.7 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, anal fistula, blood creatinine increased, dyspnoea exertional, malignant neoplasm progression, thrombocytopenia. Alimta dosage: 724 MG, OTHER; 1 DOSE. During the same period patient was treated with NIFEDIPINE, DEXAMETHASONE, FERROUS SULPHATE, NOVOLOG, VICODIN, ZETIA, DIPYRIDAMOLE, ACTOS. Patient was hospitalized. Patient died on 01/18/2007.
Alimta Side Effects Report #6057563-2
Alimta side effect was reported by a Physician from INDIA on Jan 28, 2009. Female patient, 85 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Alimta dosage: unknown. During the same period patient was treated with CISPLATIN. Patient died on 11/01/2008.
Alimta Side Effects Report #4901158-8
Alimta side effect was reported by a Health Professional from UNITED STATES on Jan 13, 2006. Male patient, 83 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, malignant neoplasm progression, neutropenia, oral intake reduced, speech disorder, weight decreased. Alimta dosage: 900 MG, INTRAVENOUS. During the same period patient was treated with VITAMIN B12. Patient was hospitalized. Patient died on 12/14/2005.
Alimta Side Effects Report #5440452-1
Alimta side effect was reported by a Physician from UNITED STATES on Aug 29, 2007. Female patient, 77 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood count abnormal, hepatic failure, malignant neoplasm progression, oesophagitis, stomatitis. Alimta dosage: unknown. During the same period patient was treated with VITAMIN B, FOLIC ACID. Patient died on 08/18/2007.
Alimta Side Effects Report #5683092-1
Alimta side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 17, 2008. Female patient, 75 years of age, was diagnosed with non-small cell lung cancer, vitamin supplementation and was treated with Alimta. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, oral discomfort, respiratory failure. Alimta dosage: 500 MG/M2, OTHER. During the same period patient was treated with VITAMIN B, FOLIC ACID, CORTICOSTEROID NOS. Patient died on 01/04/2008.
Alimta Side Effects Report #6080119-2
Alimta side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 11, 2009. Female patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: asthenia, confusional state, lethargy, malignant neoplasm progression, walking disability. Alimta dosage: 500 MG, UNK. During the same period patient was treated with FOLIC ACID, VITAMIN B, CORTICOSTEROID NOS. Patient was hospitalized. Patient died.
Alimta Side Effects Report #5489398-3
Alimta side effect was reported by a Physician from UNITED STATES on Oct 09, 2007. Female patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: atelectasis, bronchial obstruction, dyspnoea, hypoxia, malignant neoplasm progression, pleural effusion. Alimta dosage: unknown. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #4738127-7
Alimta side effect was reported by a Consumer or non-health professional from BRAZIL on July 17, 2005. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: angina pectoris, cardio-respiratory arrest, malignant neoplasm progression, myocardial infarction. Alimta dosage: unknown. During the same period patient was treated with GEMZAR, CISPLATIN. Patient was hospitalized. Patient died.
Alimta Side Effects Report #5140785-2
Alimta side effect was reported by a Physician from FRANCE on Oct 09, 2006. Male patient, 73 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: lung neoplasm malignant, malignant neoplasm progression, renal failure. Alimta dosage: unknown. Patient recovered.
Alimta Side Effects Report #5673228-0
Alimta side effect was reported by a Physician from FRANCE on Mar 12, 2008. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer, vitamin supplementation, prophylaxis and was treated with Alimta. After drug was administered, patient experienced the following side effects: dehydration, enterocolitis infectious, fatigue, gastrointestinal haemorrhage, malignant neoplasm progression, metabolic disorder
, mucosal inflammation, pancytopenia, pyrexia. Alimta dosage: 500 MG/M2, OTHER. During the same period patient was treated with FOLIC ACID, VITAMIN B, CORTICOSTEROIDS. Patient recovered.Alimta Side Effects Report #5931664-9
Alimta side effect was reported by a Physician from FRANCE on Oct 17, 2008. Male patient, 71 years of age, weighting 216.1 lb, was diagnosed with non-small cell lung cancer, vitamin supplementation, prophylaxis, pain
, hypertension, blood cholesterol and was treated with Alimta. After drug was administered, patient experienced the following side effects: dehydration, enterocolitis infectious, fatigue, gastrointestinal haemorrhage, malignant neoplasm progression, metabolic disorder , mucosal inflammation, pancreatitis acute, pancytopenia. Alimta dosage: 500 MG/M2 (1000MG) ON DAY ONE AND DAY 21.. During the same period patient was treated with FOLIC ACID, VITAMIN B, CORTICOSTEROIDS, CLASTOBAN, DOLPRONE, TAREG, LIPANTHYL. Patient was hospitalized. Patient recovered.Alimta Side Effects Report #4735312-5
Alimta side effect was reported by a Physician from UNITED STATES on July 14, 2005. Male patient, 71 years of age, weighting 220.5 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: lung neoplasm malignant, malignant neoplasm progression, neutropenia, rash
, staphylococcal sepsis. Alimta dosage: 500 MG/M2. During the same period patient was treated with GEMZAR, CENTRUM PERFORMANCE VITAMIN, VITAMIN B, DECADRON, FOLIC ACID, CARBOPLATIN. Patient died on 05/16/2005.Alimta Side Effects Report #5201514-7
Alimta side effect was reported by a Consumer or non-health professional from UNITED STATES on July 27, 2006. Male patient, 68 years of age, weighting 151.0 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Alimta dosage: unknown. During the same period patient was treated with PROTONIX, HYDROCODONE BITARTRATE, PREDNISONE, ZOFRAN, ADVAIR DISKUS, OXYCONTIN, VITAMNI B, FOLIC ACID. Patient died on 04/15/2006.
Alimta Side Effects Report #4972935-2
Alimta side effect was reported by a Pharmacist from UNITED STATES on Mar 23, 2006. Female patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: eczema
, herpes simplex , malignant neoplasm progression, oesophagitis, procedural site reaction, skin infection, white blood cell count decreased. Alimta dosage: unknown. During the same period patient was treated with CYANOCOBALAMIN, FOLIC ACID. Patient was hospitalized. Patient died.Alimta Side Effects Report #5284338-4
Alimta side effect was reported by a Physician from SOUTH AFRICA on Mar 23, 2007. Female patient, 63 years of age, was diagnosed with non-small cell lung cancer, prophylaxis, pain
, asthma and was treated with Alimta. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Alimta dosage: unknown. During the same period patient was treated with FOLIC ACID, VITAMIN B, DEXAMETHASONE, DURAGESIC, VENTOLIN. Patient died on 01/21/2007.Alimta Side Effects Report #5309913-X
Alimta side effect was reported by a Physician from SOUTH AFRICA on Apr 23, 2007. Female patient, 63 years of age, was diagnosed with non-small cell lung cancer, prophylaxis, pain
, asthma and was treated with Alimta. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Alimta dosage: unknown. During the same period patient was treated with FOLIC ACID, VITAMIN B, DEXAMETHASONE, DURAGESIC, VENTOLIN. Patient died on 01/21/2007.Alimta Side Effects Report #5747468-6
Alimta side effect was reported by a Physician from SLOVAKIA (Slovak Republic) on May 14, 2008. Male patient, 60 years of age, was diagnosed with non-small cell lung cancer, pain
, chronic obstructive pulmonary disease and was treated with Alimta. After drug was administered, patient experienced the following side effects: gastrointestinal disorder, hepatorenal failure, infection , malignant neoplasm progression, pancytopenia. Alimta dosage: unknown. During the same period patient was treated with FOLIC ACID, VITAMIN B, CORTICOSTEROIDS, TRAMADOLE, BUPRENORPHINE, BUDESONIDE, IPRATROPIUM BROMIDE. Patient was hospitalized. Patient died on 02/14/2008.Alimta Side Effects Report #5402373-X
Alimta side effect was reported by a Physician from FRANCE on July 25, 2007. Female patient, 58 years of age, weighting 207.2 lb, was diagnosed with non-small cell lung cancer, vitamin supplementation, diabetes mellitus, hypertension, prophylaxis and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, beta haemolytic streptococcal infection, candida sepsis, febrile neutropenia, malignant neoplasm progression, renal failure, thrombocytopenia. Alimta dosage: 1000 MG, OTHER. During the same period patient was treated with FOLIC ACID, VITAMIN B, METFORMINE, COKENZEN, MICARDIS, DEXAMETHASONE, DURAGESIC. Patient was hospitalized. Patient died on 04/03/2007.
Alimta Side Effects Report #6120974-0
Alimta side effect was reported by a Physician from UNITED KINGDOM on Mar 10, 2009. Male patient, 58 years of age, was diagnosed with non-small cell lung cancer, prophylaxis and was treated with Alimta. After drug was administered, patient experienced the following side effects: atrial fibrillation
, electrocardiogram qt prolonged, malignant neoplasm progression. Alimta dosage: 500 MG/M2, DAY 1 EVERY 21 DAYS. During the same period patient was treated with VITAMIN B, FOLIC ACID, DEXAMETHASONE, VANDETANIB. Patient died.Alimta Side Effects Report #4876200-3
Alimta side effect was reported by a Health Professional from UNITED STATES on Dec 22, 2005. Female patient, 58 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: lung neoplasm malignant, malignant neoplasm progression, mucosal inflammation, oesophagitis. Alimta dosage: 800 MG, INTRAVENOUS. During the same period patient was treated with VITAMIN B12, FOLIC ACID. Patient was hospitalized. Patient died on 11/11/2005.
Alimta Side Effects Report #5341777-0
Alimta side effect was reported by a Physician from UNITED STATES on May 24, 2007. Male patient, 57 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: helicobacter pylori identification test positive, malignant neoplasm progression. Alimta dosage: 500 MG/M2, UNK. Patient died.
Alimta Side Effects Report #5352661-0
Alimta side effect was reported by a Physician from UNITED STATES on June 07, 2007. Male patient, 57 years of age, was diagnosed with non-small cell lung cancer, vitamin supplementation and was treated with Alimta. After drug was administered, patient experienced the following side effects: helicobacter pylori identification test positive, malignant neoplasm progression. Alimta dosage: 500 MG/M2, UNK. During the same period patient was treated with FOLIC ACID, VITAMIN B12 NOS. Patient died.
Alimta Side Effects Report #5115151-6
Alimta side effect was reported by a Health Professional from UNITED STATES on Sept 25, 2006. Male patient, 53 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: lung neoplasm malignant, malignant neoplasm progression, performance status decreased. Alimta dosage: unknown. Patient died on 09/19/2006.
Alimta Side Effects Report #5337623-1
Alimta side effect was reported by a Physician from UNITED STATES on Jan 03, 2007. Male patient, 51 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: conjunctivitis, injection site irritation, malignant neoplasm progression. Alimta dosage: unknown. During the same period patient was treated with GEMZAR. Patient recovered.
Alimta Side Effects Report #5339539-3
Alimta side effect was reported by a Physician from UNITED STATES on Jan 03, 2007. Male patient, 51 years of age, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: conjunctivitis, injection site irritation, malignant neoplasm progression. Alimta dosage: unknown. During the same period patient was treated with GEMZAR. Patient recovered.
Alimta Side Effects Report #5731682-X
Alimta side effect was reported by a Physician from SWITZERLAND on Apr 30, 2008. Male patient, 49 years of age, weighting 213.8 lb, was diagnosed with non-small cell lung cancer, pain
and was treated with Alimta. After drug was administered, patient experienced the following side effects: gastric haemorrhage, malignant neoplasm progression. Alimta dosage: 1000 MG, UNK. During the same period patient was treated with MS CONTIN, DAFALGAN, NOVALDIN. Patient was hospitalized. Patient died on 04/21/2008.Alimta Side Effects Report #5828743-3
Alimta side effect was reported by a Physician from SWITZERLAND on July 22, 2008. Male patient, 49 years of age, weighting 213.8 lb, was diagnosed with non-small cell lung cancer, pain
and was treated with Alimta. After drug was administered, patient experienced the following side effects: gastric haemorrhage, malignant neoplasm progression, thrombocytopenia. Alimta dosage: unknown. During the same period patient was treated with MS CONTIN, DAFALGAN, NOVALGIN, VITAMIN B, FOLIC ACID, FORTECORTIN. Patient was hospitalized. Patient died on 04/21/2008.Alimta Side Effects Report #5456420-X
Alimta side effect was reported by a Physician from FRANCE on Sept 12, 2007. Male patient, 48 years of age, weighting 134.5 lb, was diagnosed with non-small cell lung cancer, vitamin supplementation and was treated with Alimta. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Alimta dosage: unknown. During the same period patient was treated with FOLIC ACID, HYDROXOCOBALAMIN, MORPHINE, ESOMEPRAZOLE MAGNESIUM. Patient was hospitalized. Patient died on 08/15/2005.
Alimta Side Effects Report #4844598-8
Alimta side effect was reported by a Physician from FRANCE on Nov 17, 2005. Male patient, 48 years of age, weighting 134.5 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, metastases to bone. Alimta dosage: unknown. During the same period patient was treated with FOLIC ACID, HYDROXOCOBALAMIN, MORPHINE, ESOMEPRAZOLE. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #5485617-8
Alimta side effect was reported by a Physician from GERMANY on Oct 02, 2007. Male patient was diagnosed with non-small cell lung cancer, pain
and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, c-reactive protein increased, dyspnoea, haemoglobin decreased, lymphocyte count decreased, malignant neoplasm progression, red blood cell count decreased, rib fracture. Alimta dosage: unknown. During the same period patient was treated with DURAGESIC, NOVALGIN, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.Alimta Side Effects Report #5486391-1
Alimta side effect was reported by a Physician from GERMANY on Oct 02, 2007. Male patient was diagnosed with non-small cell lung cancer, pain
and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, c-reactive protein increased, dyspnoea, haemoglobin decreased, lymphocyte count decreased, malignant neoplasm progression, red blood cell count decreased, rib fracture. Alimta dosage: unknown. During the same period patient was treated with DURAGESIC, NOVALGIN, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.Alimta Side Effects Report #5628157-5
Alimta side effect was reported by a Physician from FRANCE on Feb 06, 2008. Male patient, weighting 220.5 lb, was diagnosed with non-small cell lung cancer, vitamin supplementation, prophylaxis and was treated with Alimta. After drug was administered, patient experienced the following side effects: gastric disorder, malignant neoplasm progression, oedema peripheral. Alimta dosage: 500 MG/M2, OTHER. During the same period patient was treated with SPECIAFOLDINE, VITAMIN B, CORTICOSTEROID NOS. Patient died on 01/11/2008.
Alimta Side Effects Report #5809646-7
Alimta side effect was reported by a Health Professional from UNITED STATES on July 11, 2008. Female patient, weighting 153.0 lb, was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: dysarthria, malignant neoplasm progression, metastases to central nervous system, metastases to meninges, neuropathy peripheral, speech disorder. Alimta dosage: 500 MG/M2 D 1 Q 21 DAYS IV. During the same period patient was treated with ABRAXANE. Patient was hospitalized. Patient recovered.
Alimta Side Effects Report #4988510-X
Alimta side effect was reported by a Physician from UNITED STATES on Apr 07, 2006. Male patient was diagnosed with non-small cell lung cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: impaired driving ability, malignant neoplasm progression, neuropathy, peroneal nerve palsy. Alimta dosage: 500 MG/M2, INTRAVENOUS. During the same period patient was treated with GEMZAR, NAVELBINE. Patient recovered.
Alimta Side Effects Report #4567087-7
Alimta side effect was reported by a Health Professional from on Jan 11, 2005. Female patient, 63 years of age, was diagnosed with metastatic neoplasm and was treated with Alimta. After drug was administered, patient experienced the following side effects: confusional state, malignant neoplasm progression, mental status changes, metastases to central nervous system. Alimta dosage: 900 MG. During the same period patient was treated with VITAMIN B, FOLIC ACID. Patient died on 10/01/2004.
Alimta Side Effects Report #4665084-4
Alimta side effect was reported by a Physician from on May 21, 2005. Male patient, 71 years of age, weighting 123.5 lb, was diagnosed with mesothelioma
and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood pressure increased, cardiac arrest , collapse of lung, coma, hypercapnia, leukopenia, malignant neoplasm progression, myocardial ischaemia, pleural effusion. Alimta dosage: 800 MG/1 OTHER. During the same period patient was treated with CARBOPLATIN, PROPAFENONE, WARFARIN, TIZANIDINE, DEXAMETHASONE, FINASTERIDE, FOLIC ACID, VITAMIN B. Patient was hospitalized. Patient died on 04/30/2005.Alimta Side Effects Report #5691839-3
Alimta side effect was reported by a Physician from MEXICO on Mar 24, 2008. Male patient, 57 years of age, weighting 125.7 lb, was diagnosed with mesothelioma
and was treated with Alimta. After drug was administered, patient experienced the following side effects: jaundice cholestatic, malignant neoplasm progression, peripheral sensory neuropathy. Alimta dosage: 500 MG/M2, OTHER. During the same period patient was treated with CISPLATIN, DEXAMETHASONE, FOLIC ACID, VITAMIN B. Patient died on 03/17/2008.Alimta Side Effects Report #5228052-X
Alimta side effect was reported by a Physician from UNITED STATES on Oct 26, 2006. Female patient, 65 years of age, was diagnosed with lung neoplasm malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: blood pressure increased, chest discomfort, malignant neoplasm progression. Alimta dosage: 80 MG. During the same period patient was treated with CISPLATIN, VITAMIN B12, FOLIC ACID, DECADRON. Patient recovered.
Alimta Side Effects Report #5201510-X
Alimta side effect was reported by a Health Professional from UNITED STATES on July 20, 2006. Male patient, 64 years of age, was diagnosed with lung neoplasm malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Alimta dosage: unknown. During the same period patient was treated with CYANOCOBALAMIN, FOLIC ACID. Patient recovered.
Alimta Side Effects Report #5037804-0
Alimta side effect was reported by a Health Professional from UNITED STATES on May 01, 2006. Male patient, 64 years of age, was diagnosed with lung neoplasm malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: malignant neoplasm progression. Alimta dosage: unknown. Patient recovered.
Alimta Side Effects Report #5145328-5
Alimta side effect was reported by a Physician from FRANCE on May 10, 2005. Female patient, 40 years of age, was diagnosed with lung neoplasm malignant, vitamin supplementation, pyrexia and was treated with Alimta. After drug was administered, patient experienced the following side effects: bronchial carcinoma, malignant neoplasm progression, pancytopenia, renal failure. Alimta dosage: unknown. During the same period patient was treated with FOLIC ACID, VITAMIN B, MORPHINE. Patient was hospitalized. Patient died.
Alimta Side Effects Report #6111756-4
Alimta side effect was reported by a Physician from GERMANY on Mar 06, 2009. Female patient, weighting 183.0 lb, was diagnosed with lung neoplasm malignant, hypothyroidism and was treated with Alimta. After drug was administered, patient experienced the following side effects: hypoalbuminaemia, malignant neoplasm progression, shock. Alimta dosage: unknown. During the same period patient was treated with CISPLATIN, LAFOL, VITAMIN B, LANSOPRAZOL, LEVOTHYROXINE. Patient was hospitalized. Patient died on 02/13/2009.
Alimta Side Effects Report #4876228-3
Alimta side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 05, 2005. Male patient, 66 years of age, was diagnosed with lung neoplasm and was treated with Alimta. After drug was administered, patient experienced the following side effects: anger, asthenia, fatigue, irritability, malignant neoplasm progression, pain
, rash , social avoidant behaviour, weight increased. Alimta dosage: unknown. During the same period patient was treated with CARBOPLATIN, ZETIA, ZOCOR, FOLIC ACID, DEXAMETHASONE, VITAMIN B, LASIX. Patient recovered.Alimta Side Effects Report #5328840-5
Alimta side effect was reported by a Physician from FRANCE on May 14, 2007. Female patient, 67 years of age, weighting 149.9 lb, was diagnosed with lung adenocarcinoma metastatic, vitamin supplementation and was treated with Alimta. After drug was administered, patient experienced the following side effects: cerebrovascular accident, hemiplegia, malignant neoplasm progression, thrombocytopenia. Alimta dosage: 800 MG, OTHER. During the same period patient was treated with FOLIC ACID, VITAMIN B, DEXAMETHASONE. Patient was hospitalized and became disabled. Patient died.
Alimta Side Effects Report #6065300-0
Alimta side effect was reported by a Physician from UNITED STATES on Jan 29, 2009. Female patient, weighting 200.0 lb, was diagnosed with lung adenocarcinoma and was treated with Alimta. After drug was administered, patient experienced the following side effects: cardiac failure congestive, dehydration, lung infiltration, lymphadenopathy mediastinal, malignant neoplasm progression, pancytopenia, pulmonary embolism
, renal failure acute. Alimta dosage: 1000 MG, UNK. During the same period patient was treated with COUMADIN, OXYCONTIN, VICODIN. Patient was hospitalized. Patient recovered.Alimta Side Effects Report #4979535-9
Alimta side effect was reported by a Physician from NETHERLANDS on Feb 03, 2006. Male patient, 62 years of age, weighting 180.8 lb, was diagnosed with colon cancer and was treated with Alimta. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, c-reactive protein increased, cholestasis, malignant neoplasm progression, pyrexia, urinary tract infection
. Alimta dosage: 1000 MG, ONCE EVERY 3 WEEKS, INTRAVENOUS; SEE IMAGE. During the same period patient was treated with VITAMIN B12, FOLIUMZUUR, METFORMIN, GLUCOZIDE, DEXAMETHASONE. Patient was hospitalized. Patient died on 09/17/2005.Alimta Side Effects Report #4674057-7
Alimta side effect was reported by a Physician from on May 10, 2005. Female patient, 40 years of age, was diagnosed with bronchial carcinoma and was treated with Alimta. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, overdose, pancytopenia, renal failure. Alimta dosage: unknown. During the same period patient was treated with FOLIC ACID, VITAMIN B. Patient was hospitalized. Patient died.
Alimta Side Effects Report #4797342-7
Alimta side effect was reported by a Health Professional from UNITED STATES on May 23, 2005. Male patient, 54 years of age, was diagnosed with bladder cancer
and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, anorexia, fatigue, haemolytic anaemia, malignant neoplasm progression, thrombocytopenia. Alimta dosage: unknown. During the same period patient was treated with GEMZAR, VITAMIN B, FOLIC ACID, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Alimta Side Effects Report #4992347-5
Alimta side effect was reported by a Health Professional from UNITED STATES on May 25, 2005. Male patient, 54 years of age, was diagnosed with bladder cancer
and was treated with Alimta. After drug was administered, patient experienced the following side effects: anaemia, anorexia, fatigue, haemolytic anaemia, malignant neoplasm progression, thrombocytopenia. Alimta dosage: unknown. During the same period patient was treated with GEMZAR, VITAMIN B12, FOLIC ACID, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Alimta Side Effects Report #4684817-4
Alimta side effect was reported by a Consumer or non-health professional from on Mar 15, 2005. Female patient, 73 years of age, was treated with Alimta. After drug was administered, patient experienced the following side effects: haemoptysis, lip exfoliation, malignant neoplasm progression, pharyngolaryngeal pain, pyrexia. Alimta dosage: unknown. During the same period patient was treated with GEMZAR, NASUEA MEDICINE, FOLIC ACID, VITAMIN B, NAVELBINE. Patient recovered.
Alimta Side Effects Report #4990405-2
Alimta side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2005. Female patient, 73 years of age, was treated with Alimta. After drug was administered, patient experienced the following side effects: haemoptysis, lip exfoliation, malignant neoplasm progression, pharyngolaryngeal pain, pyrexia. Alimta dosage: unknown. During the same period patient was treated with GEMZAR, NAUSEA MEDICINE, FOLIC ACID, VITAMIN B12, NAVELBINE. Patient recovered.
Alimta Side Effects Report #5965945-X
Alimta side effect was reported by a Physician from SWITZERLAND on Nov 14, 2008. Male patient, 71 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Alimta. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, recall phenomenon, respiratory distress. Alimta dosage: 500 MG/M2, DAY 1 EVERY 21 DAYS. During the same period patient was treated with CORTICOSTEROID NOS, CORTICOSTEROID NOS, VITAMIN B, VITAMIN B, FOLIC ACID, FOLIC ACID, THERAPEUTIC RADIOPHARMACEUTICALS. Patient recovered.